The invention concerns a method of inhibiting both thromboxane synthetase and cyclic-AMP phosphodiesterase in a mammal having a disease characterized by elevated thromboxane levels or an imbalance of prostacyclin/thromboxane levels with a compound of the formula: ##STR1## or a pharmaceutically acceptable acid addition salt or ester thereof, wherein: X is chosen from the group consisting of: ##STR2## and a covalent bond in which R.sup.1 is H, alkyl having 1-6 carbon atoms, optionally substituted phenyl or optionally substituted phenyl lower alkyl, when R.sup.2 is H or OH, or R.sup.1 and R.sup.2 taken together represent oxo, alkylidene having 1-6 carbon atoms or optionally substituted benzylidene; R.sup.3 is H or alkyl having 1-6 carbon atoms, R.sup.4 is H and R.sup.3 and R.sup.4 are either cis or trans to each other, or R.sup.3 and R.sup.4 taken together represent a covalent bond; n is an integer from 0-3; Het is 1-imidazolyl or 3-pyridyl; and the dotted line represents an optional covalent bond.
本发明涉及一种用于抑制具有高血栓素
水平或
前列环素/血栓素平衡失调的疾病的哺乳动物中的血栓素合成酶和环
磷酸腺苷磷酸二酯酶的方法,使用式子的化合物:##STR1##或其药学上可接受的酸加合盐或酯,其中:X选自以下组中的一种:##STR2##和其中R.sup.1是H,具有1-6个碳原子的烷基,可选地取代的苯基或可选地取代的苯基低烷基,当R.sup.2为H或OH时,或者R.sup.1和R.sup.2一起表示氧杂,具有1-6个碳原子的烷基或可选地取代的苯基
甲烷基; R.sup.3是H或具有1-6个碳原子的烷基,R.sup.4为H且R.sup.3和R.sup.4要么顺式排列,要么反式排列,或者R.sup.3和R.sup.4一起表示共价键; n是0-3的整数; Het是1-
咪唑基或3-
吡啶基; 而点线表示可选的共价键。